Parmax Pharma (540359.BO) Stock Price
Parmax Pharma Price
Revenue has compounded at 35.2% per year over the past 2 years to 282.04 M INR. Parmax Pharma's net margin stands at -7.4%, down from -0.7% several years earlier.
Parmax Pharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Parmax Pharma business model & stock analysis
Frequently asked questions about Parmax Pharma
Converted at the current exchange rate, the Parmax Pharma share trades at 1.30 EUR (137.75 INR).
The revenue cannot currently be calculated for Parmax Pharma.
The profit cannot currently be calculated for Parmax Pharma.
The P/E ratio cannot be calculated for Parmax Pharma at the moment.
The P/S cannot be calculated for Parmax Pharma currently.
The Eulerpool Quality Score for Parmax Pharma is 1/10.
The ISIN of Parmax Pharma is INE240T01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Parmax Pharma is 540359.BO. The ticker symbol is used to trade Parmax Pharma shares on the stock exchange.
Parmax Pharma stock
Parmax Pharma Peer Group
Parmax Pharma FIGI
All fundamentals and in-depth analysis of Parmax Pharma
Our stock analysis for Parmax Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Parmax Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.